BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12921117)

  • 1. Plasma separator Plasmaflo OP.
    Hirata N; Shizume Y; Shirokaze J; Suemitsu J; Yoshida H; Yamawaki N
    Ther Apher Dial; 2003 Feb; 7(1):64-8. PubMed ID: 12921117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure and characteristics of polypropylene hollow fiber membrane plasma separator.
    Sakai M; Matsunami S
    Ther Apher Dial; 2003 Feb; 7(1):69-72. PubMed ID: 12921118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directions for use: Plasmaflo AP-05H (L) Asahi plasma separator 0.5 m2.
    Ther Apher; 1997 Nov; 1(4):379-88. PubMed ID: 10225737
    [No Abstract]   [Full Text] [Related]  

  • 4. Maximal flow rates and sieving coefficients in different plasmafilters: effects of increased membrane surfaces and effective length under standardized in vitro conditions.
    Unger JK; Haltern C; Dohmen B; Rossaint R
    J Clin Apher; 2002; 17(4):190-8. PubMed ID: 12494412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility of four plasmapheresis membranes in patients treated for hypercholesterolemia.
    Böhler J; Donauer K; Köster W; Schollmeyer PJ; Wieland H; Hörl WH
    Am J Nephrol; 1991; 11(6):479-85. PubMed ID: 1819214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane plasmapheresis and the developing technology of plasma therapy.
    Smith JW; Malchesky PS; Nosé Y
    Cleve Clin Q; 1984; 51(1):135-42. PubMed ID: 6370505
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasmapheresis with membrane type plasma separator].
    Michikojima A
    Nihon Rinsho; 2004 May; 62 Suppl 5():313-8. PubMed ID: 15197936
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma separation using a membrane.
    Hirano R; Namazuda K; Suemitsu J; Harashima T; Hirata N
    Transfus Apher Sci; 2017 Oct; 56(5):649-653. PubMed ID: 28923773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement metabolism during membrane plasma separation.
    McLeod BC; Viernes A; Sassetti RJ
    Artif Organs; 1983 Nov; 7(4):443-9. PubMed ID: 6651583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of polyethylene membrane for plasma separation.
    Sato H; Malchesky PS; Matsubara S; Nosé Y
    Artif Organs; 1983 May; 7(2):213-20. PubMed ID: 6870597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The safety problem of the membrane separation of plasma].
    Gromov MI
    Gematol Transfuziol; 1993 Jan; 38(1):41-2. PubMed ID: 8020706
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic apheresis application using membrane plasma fractionation technology: present scope and limitations.
    Sueoka A
    Ther Apher; 2000 Jun; 4(3):211-2. PubMed ID: 10910022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Organon Teknika Plasmapur system with new software and two types of filter.
    Eijkhout HW; Van Driessche P; Schade JH; Hack CE; De Wit HJ
    Transfus Sci; 1991; 12(1-2):91-9. PubMed ID: 10149538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-needle membrane plasmapheresis. In vivo comparison of plasma separator performances.
    Lambrecht L; Vanholder R; Ringoir S
    Blood Purif; 1988; 6(2):77-84. PubMed ID: 3395473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood purification therapies using dextran sulfate cellulose columns Liposorber and Selesorb.
    Asahi T; Yamamoto T; Kutsuki H
    Ther Apher Dial; 2003 Feb; 7(1):73-7. PubMed ID: 12921119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membranes and polymer structures--biocompatibility aspects with respect to production limits.
    Ansorge W; Spindler E; Vienken J; Baurmeister U
    Transfus Sci; 1993 Apr; 14(2):199-209. PubMed ID: 10148613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of a polyethersulfone hollow fiber plasma separator by animal experiment.
    Zhao CS; Liu T; Lu ZP; Cheng LP; Huang J
    Artif Organs; 2001 Jan; 25(1):60-3. PubMed ID: 11167562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal volume of processed plasma and total number of selective plasmapheresis sessions in the treatment of patients with severe generalized myasthenia gravis.
    Yeh JH; Chiu HC
    J Clin Apher; 1999; 14(4):177-80. PubMed ID: 10611627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high efficiency membrane separator for donor plasmapheresis.
    Bellhouse BJ; Lewis RW
    ASAIO Trans; 1988; 34(3):747-54. PubMed ID: 3058185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study for large-scale plasma procurement using automated plasmapheresis.
    Robinson AE; Penny AF; Smith J; Tovey DL
    Vox Sang; 1983 Mar; 44(3):143-50. PubMed ID: 6220520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.